Lv52
990 积分 2022-10-31 加入
The past, present and future of de novo protein design
1小时前
已完结
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma
1天前
已完结
AI-Driven Design Platforms of Next-Generation Antibody Therapeutics
1天前
已完结
Design of bispecific antibody Fc region employing a shark-human chimeric and asymmetric format
12天前
已完结
Antibody engineering
13天前
已完结
Complementarity of Deep Learning and Physics-Based Approaches in the Design of New Antibodies
13天前
已完结
Antibody engineering : methods and protocols
13天前
已完结
Introduction to Antibody Engineering
13天前
已完结
Dual-epitope targeting of TSLP to simultaneously block TSLPR and IL-7Rα with a Biparatopic nanobody
17天前
已完结
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
1个月前
已完结
皖公网安备34019202002308
